Emma Link

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis et al. · The Lancet · 2020 · 2K citations

Medicine, Nuclear Medicine, Oncology +17

First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study

Amit Khot, Natalie Brajanovski, Donald P. Cameron et al. · Cancer Discovery · 2019 · 203 citations

Medicine, Oncology, Pharmacology +15

Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study

Jemma C. Hopewell, Sarah Parish, Alison Offer et al. · European Heart Journal · 2012 · 110 citations · Full text

Life Sciences, Genetics, Pharmacology +16

Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study

Boon Chua, Emma Link, Ian Kunkler et al. · The Lancet · 2022 · 107 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Twenty-Five-Year Experience With Radical Chemoradiation for Anal Cancer

Jonathan M. Tomaszewski, Emma Link, Trevor Leong et al. · International Journal of Radiation Oncology*Biology*Physics · 2011 · 86 citations

Medicine, Oncology, Surgery +10